Hysbysiad gwybodaeth ymlaen llaw
Cais am gystadleuaeth yw’r hysbysiad hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Porton Biopharma
Salisbury
UK
E-bost: jeff.pike@portonbiopharma.com
NUTS: UKK1
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.portonbiopharma.com/
I.2) Caffael ar y cyd
Caiff y contract ei ddyfarnu gan gorff prynu canolog
I.3) Cyfathrebu
Mae'r dogfennau caffael ar gael ar gyfer mynediad uniongyrchol anghyfyngedig a llawn, yn rhad ac am ddim ar:
https://portonbiopharma.bravosolution.co.uk
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Rhaid anfon tendrau neu geisiadau i gymryd rhan yn electronig at:
https://portonbiopharma.bravosolution.co.uk
Rhaid anfon tendrau neu geisiadau i gymryd rhan i'r cyfeiriad uchod:
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
PBL ICT Infrastructure
II.1.2) Prif god CPV
72000000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
Porton Biopharma (PBL) is undertaking an extensive programme of work to create a new ICT core infrastructure, following the approval of a 5-year technical strategy by the business, mid-2019. Beginning with a limited scope ‘Pilot’ phase, the primary hosting and network solutions, cyber-security controls and use-cases must be trialled and refined. The duration of the pilot is expected to be circa 6 months.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKK1
II.2.4) Disgrifiad o’r caffaeliad
Porton Biopharma (PBL) is undertaking an extensive programme of work to create a new ICT core infrastructure, following the approval of a 5-year technical strategy by the business, mid-2019. Beginning with a limited scope ‘Pilot’ phase, the primary hosting and network solutions, cyber-security controls and use-cases must be trialled and refined. The duration of the Pilot is expected to be circa 6 months.
Having been fully dependent on Public Health England (PHE) ICT services and infrastructure since its inception in 2015, it is strategically important for PBL to now establish a completely new and independent ICT operation.
The following technical strategy has been approved for implementation. Within the limited scope of a Pilot phase, ICT services organisations are invited to express an interest in designing, supplying and building this environment in close collaboration with a dedicated PBL team, on a fixed-price basis.
— HCI-based hosting platform – currently specified as Dell-EMC VxRail stretch-cluster,
— physical network underlay (limited scope),
— perimeter firewall (to be specified),
— SDN network overlay technology (circa 30 endpoints) – currently specified as Cisco’s SDA solution,
— Horizon VDI for application and desktop virtualisation (2-3 pilot application environments).
— MS Windows domain(s) dedicated to PBL – including all domain-related services and inter-domain trust for testing purposes,
— coherent IDAM/RBAC ecosystem.
The Pilot infrastructure will form the basis of a broader enterprise ICT core infrastructure that will be built-out in subsequent programme phases.
PBL operates within a highly regulated pharmaceutical environment (within FDA and MHRA codes/guidance for GMP IT). Close collaboration with PBL and adherence to ITIL principles and local IT infrastructure qualification controls will be critical to ensure compliance with regulatory standards from day-1.
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 24
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section III: Gwybodaeth gyfreithiol, economaidd, ariannol a thechnegol
III.1) Amodau ar gyfer cymryd rhan
III.1.2) Statws economaidd ac ariannol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.1.3) Gallu technegol a phroffesiynol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.2) Amodau sy’n gysylltiedig â’r contract
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn gyfyngedig
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.2) Terfyn amser i ddatganiadau o ddiddordeb ddod i law
Dyddiad:
24/01/2020
Amser lleol: 17:00
IV.2.4) Ym mha iaith/ieithoedd y gellir cyflwyno tendrau neu geisiadau i gymryd rhan
EN
Section VI: Gwybodaeth ategol
VI.2) Gwybodaeth am lifau gwaith electronig
Defnyddir archebion electronig
Derbynnir anfonebau electronig
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
Porton Biopharma
Salisbury
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
10/12/2019